Compliance Department. GSK shall include a summary of the Non-Promotional Monitoring Program and the results of the Non-Promotional Monitoring Program as part of each Annual Report. As part of each Annual Report, GSK also shall provide the OIG with descriptions of any instances identified through the Non-Promotional Monitoring Program in which it was determined that improper promotion of Government Reimbursed Products occurred or the activities violated GSK’s requirements or Policies and Procedures, and a description of the action(s) that GSK took as a result of such determinations. GSK shall make the documents relating to the Non-Promotional Monitoring Program available to the OIG upon request. GlaxoSmithKline LLC Corporate Integrity Agreement
Appears in 4 contracts
Samples: Corporate Integrity Agreement, Corporate Integrity Agreement, Corporate Integrity Agreement
